Healthy Volunteers Clinical Trial
Official title:
The Relationship Between Temporal Discrimination and Cortical Excitability in Humans
This study will use repetitive transcranial magnetic stimulation, or rTMS (magnetic
stimulation to the brain), to examine how the brain distinguishes between two signals that
are spaced very closely in time. The ability to tell the difference between sensory signals
is important to understanding sensory input. Understanding how this works may help to develop
new treatments for sensory deficits.
Healthy volunteers 18 years of age and older may be eligible for this study. Participants
undergo the following procedures during three visits to the NIH Clinical Center:
rTMS - all visits (sham rTMS on one visit) :
For TMS, a wire coil is held on the scalp. A brief electrical current passed through the coil
creates a magnetic pulse that stimulates the brain. During the stimulation, the subject may
be asked to tense certain muscles slightly or perform other simple actions.
Theta burst stimulation (TBS) - all visits (sham TBS on one visit):
Same as TMS, but brief pulses of electrical current are passed through the coil. Subjects
undergo intermittent TBS on one visit and continuous TBS on another.
Somatosensory evoked potential (SEP) - all visits:
SEP tests how sensory information travels along the nerves to the spinal cord and brain. A
small metal disk electrode placed on an arm delivers a small electrical shock. Electrodes
placed on the scalp record how the impulse travels over the nerve pathways to the cerebral
cortex of the brain. EEG (see below) records what sensory information the brain is detecting
and processing. Paired-pulse SEP is done before and after TBS.
Temporal discrimination threshold - all visits:
This test investigates the brain's ability to discriminate sensory information. Electrodes
are placed on the subject's wrist. Two electrical pulses are delivered to the nerve at the
wrist at different spaced intervals to determine when the subject feels the two pulses are
fused into one. This test is done before and after TBS.
Electroencephalography (EEG) - all visits:
This test records brain waves (electrical activity of the brain). Electrodes are placed on
the scalp with an electrode cap. The spaces between the electrodes and the scalp are filled
with a gel that conducts electrical activity.
Objective:
The ability to discriminate successive signals separated by time intervals in the
millisecond-range is an important element in analyzing the temporal characteristics of
sensory input. When two identical stimuli are presented with a sufficient time interval
between them, they are readily perceived as being two separate events. As they are presented
progressively closer together, there comes a point when the two separate stimuli are
perceived as one. However, the neural mechanism of temporal discrimination is unclear.
Therefore, our major objective is to analyze, in detail, the effect of cortical excitability
and inhibition on temporal sensory discrimination in healthy subjects.
Study Population:
We intend to study 25 adult healthy volunteers.
Design:
Assuming the cortical circuit in the somatosensory area plays an important role in temporal
discrimination, we plan to investigate the relationship between cortical excitability and the
ability of temporal discrimination. We hypothesize that the extent of cortical excitability
affects the ability to discriminate. Cortical excitability will be modulated by using
repetitive transcranial magnetic stimulation (rTMS). Comparison of cortical excitability
changes will be determined before and after rTMS in the primary somatosensory cortex (SI).
The change in cortical information processing in SI will be studied using multi-channel
electroencephalography (EEG) recording of paired-pulse somatosensory evoked potentials (SEPs)
delivered at rest. Activity assessment in the cortical circuit will be measured by the
recovery curve of the amplitude of paired-pulse SEPs.
Outcome Measures:
The primary outcome measure will be the change in amplitude of the paired-pulse SEP component
(P27) in 5-ms interstimulus interval condition for three types of rTMS. The secondary outcome
will be the amplitude of paired-pulse SEP components during other interstimulus interval
conditions (10 to 200 ms).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |